BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22269828)

  • 21. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
    Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
    Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.
    Hong EH; Song JH; Shim A; Lee BR; Kwon BE; Song HH; Kim YJ; Chang SY; Jeong HG; Kim JG; Seo SU; Kim H; Kwon Y; Ko HJ
    PLoS One; 2015; 10(6):e0131089. PubMed ID: 26098681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection.
    Geng ZK; Li YQ; Cui QH; DU RK; Tian JZ
    Chin J Nat Med; 2019 Sep; 17(9):650-662. PubMed ID: 31526500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral burden, inflammatory milieu and CD8
    Nüssing S; Mifsud E; Hensen L; Koutsakos M; Wang Z; Kedzierski L; Mercuri F; Rossignol JF; Hurt AC; Kedzierska K
    Influenza Other Respir Viruses; 2020 Nov; 14(6):678-687. PubMed ID: 32588557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
    Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.
    Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Jang SI; Kim H; Cheong HJ; Song JW; Song KJ; Baek LJ; Park MS
    PLoS One; 2014; 9(7):e101325. PubMed ID: 24992479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.
    Smee DF; Julander JG; Tarbet EB; Gross M; Nguyen J
    Antiviral Res; 2012 Oct; 96(1):13-20. PubMed ID: 22809862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.
    Smee DF; Barnard DL; Jones SM
    Antiviral Res; 2016 Dec; 136():45-50. PubMed ID: 27771390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus.
    Julander JG; Hagloch J; Latimer S; Motter N; Dagley A; Barnard DL; Smee DF; Morrey JD
    Antiviral Res; 2011 Nov; 92(2):228-36. PubMed ID: 21867731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-viral activity of a complex of the glycyrrhizic acid-alpha-glutamyltryptophan against the experimental lethal influenza infection in white mice caused by the oseltamivir-resistant strain of the virus].
    Smirnov VS; Garshinina AV; Shtro AA; Anikin VB; Galochkina AV; Beliavskaia SV; Zarubaev VV
    Vopr Virusol; 2014; 59(5):31-8. PubMed ID: 25895209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of rosuvastatin in a murine model of influenza A infection.
    Radigan KA; Urich D; Misharin AV; Chiarella SE; Soberanes S; Gonzalez A; Perlman H; Wunderink RG; Budinger GR; Mutlu GM
    PLoS One; 2012; 7(4):e35788. PubMed ID: 22536437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection.
    Oldstone MB; Teijaro JR; Walsh KB; Rosen H
    Virology; 2013 Jan; 435(1):92-101. PubMed ID: 23217619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro and in vivo anti-influenza virus activity of ribavirin injection].
    Gao RM; Li XQ; He WY; Jiang JD; Li YH
    Yao Xue Xue Bao; 2010 Mar; 45(3):403-7. PubMed ID: 21351521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A; Abed Y; Rhéaume C; Boivin G
    Antiviral Res; 2014 May; 105():54-8. PubMed ID: 24583158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.